Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Merck & Co Inc banner

Merck & Co Inc
XMUN:6MK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
XMUN:6MK
Watchlist
Price: 127.96 EUR -0.31% Market Closed
Market Cap: €324.3B
Write Note Create Alert Ask AI

Wall St Price Targets

6MK Price Targets Summary
Merck & Co Inc

Wall Street analysts forecast 6MK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 6MK is 135.2 EUR with a low forecast of 92.18 EUR and a high forecast of 169.75 EUR.

6MK Lowest Forecast
Wall Street Target
€92.18
-28% Downside
6MK Average Forecast
Wall Street Target
€135.2
6% Upside
6MK Highest Forecast
Wall Street Target
€169.75
33% Upside
Lowest Forecast
Price Target
92.18 EUR
28% Downside
Average Forecast
Price Target
135.2 EUR
6% Upside
Highest Forecast
Price Target
169.75 EUR
33% Upside
Merck & Co Inc Competitors:
Price Targets

Revenue
Forecast

2% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
2% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.

What are analyst estimates?

Gross Profit
Forecast

4% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
4% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 8 years is 2%.

What are analyst estimates?

Operating Income
Forecast

7% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
7% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 2%.

What are analyst estimates?

Pre-Tax Income
Forecast

7% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss
7% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 14%.

What are analyst estimates?

Net Income
Forecast

9% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-47%
Average Miss
9% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 8 years is 4%.

What are analyst estimates?

Continue 6MK Research

Summary
6MK intrinsic value, competitors valuation, and company profile.
DCF Valuation
6MK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
6MK stock valuation using valuation multiples.
Wall St Estimates
6MK price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
6MK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Merck & Co Inc listings:
NYSE • USD
MRK
 LSE • USD
0QAH
 XETRA • EUR
6MK
 F • EUR
6MK
 XHAM • EUR
6MK
 BMV • MXN
MRK
 VSE • EUR
MRK
 SGO • USD
MRK
 SWB • EUR
6MK
 DUS • EUR
6MK
 XHAN • EUR
6MK
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 6MK's stock price target?
Price Target
135.2 EUR

According to Wall Street analysts, the average 1-year price target for 6MK is 135.2 EUR with a low forecast of 92.18 EUR and a high forecast of 169.75 EUR.

What is the Revenue forecast for Merck & Co Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.

What is the Gross Profit forecast for Merck & Co Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 8 years is 2%.

What is the Operating Income forecast for Merck & Co Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 2%.

What is the Pre-Tax Income forecast for Merck & Co Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for Merck & Co Inc?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 8 years is 4%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.